Incidence and impact of adverse drug events contributing to hospital readmissions in kidney transplant recipients.

ABSTRACT:

Background

The incidence and impact of adverse drug events (ADEs) leading to hospitalization and as a predominant risk factor for late graft loss has not been studied in transplantation.

Methods

This was a longitudinal cohort study of adult kidney recipients transplanted between 2005 and 2010 and followed through 2013. There were 3 cohorts: no readmissions, readmissions not due to an adverse drug event, and adverse drug events contributing to readmissions. The rationale of the adverse drug events contribution to the readmission was categorized in terms of probability, preventability, and severity.

Results

A total of 837 patients with 963 hospital readmissions were included; 47.9% had at least one hospital readmission and 65.0% of readmissions were deemed as having an

SUBMITTER: Arms MA 

PROVIDER: S-EPMC5780193 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature